Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis
University of Erlangen-Nürnberg Medical School
132 participants
Jul 1, 2023
INTERVENTIONAL
Conditions
Summary
IMMO-LDRT02 is a prospective, placebo-controlled, double-blind, randomized trial to investigate the clinical efficacy of low dose radiation therapy (LDRT) in the treatment of arthrosis. Newly diagnosed or already existing arthroses of the fingers, wrists, shoulders, knees, ankles and feet will be enclosed. Finally, the evidence of clinical benefit from LDRT (6 x 0.5 Gy) will be compared to the placebo group (6 x 0 Gy), by determination via a visual analog scale and identification of immunological changes.
Eligibility
Inclusion Criteria8
- Diagnosed osteoarthritis according to ACR criteria (exclusion of other other arthritides and chronic rheumatoid arthritis via laboratory tests):
- Finger and wrist osteoarthritis
- Elbow arthrosis
- Shoulder arthrosis
- Knee arthrosis
- Ankle and foot joint arthrosis
- First time application of low-dose radiotherapy (LDRT) of the affected joint.
- Willingness to cooperate and accessibility of the patients (geographical proximity) for treatment and Follow-up care
Exclusion Criteria6
- Patients with tumor diseases
- People capable of childbearing or procreation who do not take consistent contraceptive measures during therapy
- Persistent drug, medication or alcohol abuse
- Patients for whom, in the physician's judgment, participation is not justifiable with regard to their well-being due to temporary withdrawal of standard medication.
- Patients in whom the diagnosis of osteoarthritis of the affected joint cannot be made without doubt. To establish the diagnosis, the guidelines of the American College of Rheumatology (ACR) are followed.
- Earlier radiation therapy for treatment of cancer
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
12 times 0.5 Gy
6 times 0.0 Gy
6 times 1.0 Gy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05887284